Security key
00688A205
Adial Pharmaceuticals, Inc. - Common Stock (ADIL)
CUSIP: 00688A205
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 5,493,768
- Total 13F shares
- 283,661
- Share change
- +107,613
- Total reported value
- $325,599
- Price per share
- $1.15
- Number of holders
- 13
- Value change
- +$119,966
- Number of buys
- 8
- Number of sells
- 6
Report period
Q2 2024
Institutions
13
Top holders
10
ADIL full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
ADIAL PHARMACEUTICALS, INC. SEC filings
ADIAL PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00688A205
Recent filing periods:
Ownership snapshot
Top shareholders of ADIL - Adial Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
Lead holder
RENAISSANCE TECHNOLOGIES LLC
13D/G signal
—
Evidence rows
16
Latest as of
31 Mar 2024
13F
3/4/5
Lead comparable stake: 0.93%
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.93%
|
$68,000
51,100 shares
|
— | 31 Mar 2024 |
| Manchester Capital Management LLC |
13F
Company
|
0.88%
|
$63,970
48,097 shares
|
— | 31 Mar 2024 |
| HRT FINANCIAL LP |
13F
Company
|
0.65%
|
$47,000
35,767 shares
|
— | 31 Mar 2024 |
| Virtu Financial LLC |
13F
Company
|
0.37%
|
$27,000
20,469 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
0.14%
|
$10,160
7,639 shares
|
— | 31 Mar 2024 |
| UBS Group AG |
13F
Company
|
0.1%
|
$7,616
5,726 shares
|
— | 31 Mar 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.08%
|
$6,151
4,625 shares
|
— | 31 Mar 2024 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
0.05%
|
$3,325
2,500 shares
|
— | 31 Mar 2024 |
| Headlands Technologies LLC |
13F
Company
|
0%
|
$85
64 shares
|
— | 31 Mar 2024 |
| Abound Wealth Management |
13F
Company
|
0%
|
$36
27 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
0%
|
$20
15 shares
|
— | 31 Mar 2024 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0%
|
$15
11 shares
|
— | 31 Mar 2024 |
| Qube Research & Technologies Ltd |
13F
Company
|
0%
|
$11
8 shares
|
— | 31 Mar 2024 |
| William B. Stilley III |
3/4/5
Director
|
—
mixed-class rows
|
$530,200
1,311,779 shares
mixed-class rows
|
— | 23 May 2023 |
| Joseph Truluck |
3/4/5
Chief Financial Officer
|
—
mixed-class rows
|
$111,411
290,139 shares
mixed-class rows
|
— | 25 Mar 2024 |
| Dr. Bankole Johnson |
3/4/5
Director
|
—
class O/S missing
|
—
40,000 shares
|
— | 23 May 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
283,661
Rows loaded
13
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
13
Q2 2024 holders
13
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.